文献速递乳房整形与再造创面修复

30天结局足够吗?假体乳房再造术后晚期感染性再入院

Are 30-Day Outcomes Enough? Late Infectious Readmissions following Prosthetic-Based Breast Reconstruction.
PubMed 文献 · Plast Reconstr Surg · 2019-01-01

该研究利用2013–2014年全国再入院数据库,识别接受假体乳房再造的乳腺癌患者中因感染再入院者,分析早期(0–30天)与晚期(31–90天)感染性再入院的预测因素。总体感染性再入院率为4.1%,其中50.7%发生于晚期,39.5%的感染性再入院需取出假体,且55.1%的取出发生于晚期再入院。结论认为30天再入院率不足以作为乳房再造的质量指标。

要点

  • 假体乳房再造感染性再入院中约半数发生于31–90天,30天指标会遗漏。
  • 感染性再入院者39.5%需取出假体,其中55.1%发生在晚期再入院。
  • 低收入、糖尿病和肥胖是感染性再入院的独立预测因素。

核心结论

  • 传统30天再入院率因晚期感染性再入院(多需取出假体)而不适合作为乳房再造的质量指标。
  • 早期与晚期感染性再入院具有不同的预测因素,针对这些因素的干预可能减少再入院。

研究设计与样本

  • 回顾性队列研究,使用2013–2014年全国再入院数据库,加权样本中识别18338例接受假体(植入物与组织扩张器)乳房再造的乳腺癌患者。
  • 采用单因素和多因素logistic回归模型识别早期(0–30天)与晚期(31–90天)感染性再入院及取出假体的预测因素。

主要发现

  • 总体感染性再入院率为4.1%(n=759),其中49.3%发生于早期,50.7%发生于晚期。
  • 感染性再入院中39.5%需取出假体,其中55.1%发生于晚期感染性再入院。
  • 75%的感染性再入院和取出假体发生于初次手术后49天内。
  • 家庭年收入中位数低于40000美元(p=0.035)、糖尿病(p=0.038)和肥胖(p=0.004)是感染性再入院的独立预测因素。
  • 糖尿病(p=0.049)和高血压(p=0.011)是早期再入院的独立预测因素;家庭年收入中位数低于40000美元(p=0.049)、肥胖(p=0.006)和初次手术住院时间延长(p=0.028)是晚期再入院的独立预测因素。

关键数值与推荐

  • 未识别出取出假体的统计学显著独立预测因素。

临床怎么用

  • 评估假体乳房再造质量时应关注术后90天内的感染性再入院,而非仅30天。
  • 对低收入、糖尿病、肥胖及住院时间较长的患者加强围手术期管理与随访,可能减少感染性再入院。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical-site infection is a major concern in prosthetic-based breast reconstruction. Thirty-day postoperative readmission rates are a common quality metric, but little is known about readmission rates for later infections. METHODS: Using the 2013 to 2014 Nationwide Readmissions Database, the authors identified breast cancer patients undergoing breast reconstruction with implants and tissue expanders who had an infectious readmission. The authors used univariate and multivariate logistic regression models to identify predictors of infectious readmission and explantation within the early (0 to 30 days) and late (31 to 90 days) postoperative periods. RESULTS: In the weighted sample, the authors identified 18,338 patients undergoing prosthetic-based breast reconstruction. The overall infectious readmission rate was 4.1 percent (n = 759): 49.3 percent occurred early and 50.7 percent occurred late. Of the infectious readmissions, 39.5 percent required explantation, 55.1 percent of which occurred during a late infectious readmission. Seventy-five percent of these infectious readmissions and explantations occurred within 49 days of initial surgery. Median annual household income less than $40,000 (p = 0.035), diabetes (p = 0.038), and obesity (p = 0.004) were independent predictors of infectious readmission. Diabetes (p = 0.049) and hypertension (p = 0.011) were independent predictors of early readmission. Median annual household income less than $40,000 (p = 0.049), obesity (p = 0.006), and increasing length of stay during the index procedure (p = 0.028) were independent predictors of late readmission. No statistically significant independent predictors for explantation were identified. CONCLUSIONS: Traditional 30-day readmission rates are not an adequate quality metric for breast reconstruction given the number of late postoperative readmissions, many of which lead to explantation. Early and late infectious readmissions have different predictors. Interventions targeting these predictors may decrease the number of readmissions, thus reducing cost and improving quality. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Collier W, Scheefer Van Boerum M, Kim J, et al. Are 30-Day Outcomes Enough? Late Infectious Readmissions following Prosthetic-Based Breast Reconstruction. Plast Reconstr Surg. 2019. PMID: 31461001. doi:10.1097/PRS.0000000000005903

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。